BioSpace News Archive

Vulnerabilities found in BD Alaris Gateway Workstation affirmed by ICS-CERT with CVSS scores of 10.0 and 7.3 respectively

Health Maintenance Organizations created the capitation method of payment, touted in the 1990s as the wave of the future, which would contain runaway medical costs, writes Lawrence Huntoon, M.D., Ph.D., in the summer issue of the Journal of American Physicians and Surgeons.

An international study led by scientists in Oakland, Calif., and Munich, Germany, may offer hope to children and adults with a rare and debilitating genetic disorder, Pantothenate Kinase-associated neurodegeneration (PKAN), as well as a potentially new approach to treat other neurodegenerative disorders such as Alzheimer’s, Parkinson’s disease and multiple sclerosis.

IQVIA™ (NYSE:IQV) today announced that Ferring Pharmaceuticals, a global leader in reproductive health, women’s health and other medical therapies, has selected IQVIA Technologies’ Orchestrated Customer Engagement (OCE) platform for global deployment across more than 50 markets.

Bristol-Myers Squibb Company (NYSE:BMY) today announced data from a Phase IV mechanistic study exploring differences in the cellular and molecular mechanisms by which ORENCIA® (abatacept) and another treatment, adalimumab, interfere with disease progression in moderate-to-severe early rheumatoid arthritis (RA) patients seropositive for certain autoantibodies

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

The EndBrainCancer Initiative held its 8th Annual “Brains Matter” Dinner on May 15th raising $57,500 for its work.

Hagens Berman Sobol Shapiro LLP, with nine offices in eight cities around the country and eighty attorneys, reminds investors in Apyx Medical Corporation (NASDAQ: APYX) of the June 17, 2019 Lead Plaintiff deadline in the securities class action, Pritchard v. Apyx Medical Corp. et al., No. 8:19-cv-00919, filed in the United States District Court for the Middle District of Florida.

The Institute of Cancer Research, London, today (Thursday) announces the appointment of a leading international expert in research and development IT at GlaxoSmithKline (GSK) to lead its information and communication technologies.

Almac Clinical Services, part of the Almac Group, has today announced the launch of Almac Adapt™ - an innovative Just in Time Manufacturing (JTM) solution.